Last updated on February 2020

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis


Find a site near you

Start Over

Research Site

Fountain Valley, CA United States
  Connect »

Research Site

Santa Monica, CA United States
  Connect »

Research Site

Alpharetta, GA United States
  Connect »

Research Site

West Dundee, IL United States
  Connect »

Research Site

New Albany, IN United States
  Connect »

Research Site

Overland Park, KS United States
  Connect »

Research Site

Louisville, KY United States
  Connect »

Research Site

Clarkston, MI United States
  Connect »

Research Site

Henderson, NV United States
  Connect »

Research Site

Stony Brook, NY United States
  Connect »

Research Site

Nashville, TN United States
  Connect »

Research Site

Dallas, TX United States
  Connect »

Research Site

Spokane, WA United States
  Connect »

Research Site

Sydney, Australia
  Connect »

Research Site

Woolloongabba, Australia
  Connect »

Research Site

Carlton, Australia
  Connect »

Research Site

London, ON Canada
  Connect »

Research Site

Mississauga, ON Canada
  Connect »

Research Site

Newmarket, ON Canada
  Connect »

Research Site

Toronto, ON Canada
  Connect »

Research Site

Southampton, United Kingdom
  Connect »

Research Site

Surrey, BC Canada
  Connect »

Research Site

Markham, ON Canada
  Connect »

Research Site

Praha 1, Czechia
  Connect »

Research Site

Sakai-shi, Japan
  Connect »

Research Site

Parkville, Australia
  Connect »

Research Site

Dundee, United Kingdom
  Connect »

Research Site

London, United Kingdom
  Connect »

Research Site

New York, NY United States
  Connect »

Research Site

Ottawa, ON Canada
  Connect »

Research Site

Novy Jicin, Czechia
  Connect »

Research Site

Tallinn, Estonia
  Connect »

Research Site

Ventspils, Latvia
  Connect »

Research Site

Springfield, IL United States
  Connect »

Research Site

Ostrava-Poruba, Czechia
  Connect »

Research Site

Budapest, Hungary
  Connect »

Research Site

Miskolc, Hungary
  Connect »

Research Site

Shinagawa-ku, Japan
  Connect »

Research Site

Barcelona, Spain
  Connect »

Research Site

Fremantle, Australia
  Connect »

Research Site

Warszawa, Poland
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Sapporo-shi, Japan
  Connect »

Research Site

Shinjuku-ku, Japan
  Connect »

Research Site

Takaoka-shi, Japan
  Connect »

Research Site

Bucheon-si, Gyeonggi-do, Korea, Republic of
  Connect »

Research Site

Busan, Korea, Republic of
  Connect »

Research Site

Seoul, Korea, Republic of
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Suwon-si, Gyeonggi-do, Korea, Republic of
  Connect »

Research Site

Chernivtsi, Ukraine
  Connect »

Research Site

Uzhhorod, Ukraine
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Obihiro-shi, Japan
  Connect »

Research Site

Chiyoda-ku, Japan
  Connect »

Research Site

Zaporizhzhia, Ukraine
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Praha 8, Czechia
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Hannover, Germany
  Connect »

Research Site

Debrecen, Hungary
  Connect »

Research Site

Sakura-shi, Japan
  Connect »

Research Site

Fukuoka-shi, Japan
  Connect »

Research Site

Nishinomiya-shi, Japan
  Connect »

Research Site

Nagasaki-shi, Japan
  Connect »

Research Site

Bunkyo-ku, Japan
  Connect »

Research Site

Ivano-Frankivsk, Ukraine
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Lausanne, Switzerland
  Connect »